Immunosuppressive constituents from urtica dentata hand

Journal of Asian Natural Products Research

Volumn 12, Issue 8, 2010, Pages 707-713

  Hou, Wen Rui ^a   Su, Zhi Qiang ^b   Pi, Hui Fang ^a   Yao, Guang Min ^a   Zhang, Peng ^a   Luo, Xiang ^a   Xie, Sheng Nan ^a   Xiang, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

biscoumarin; immunosuppression; Urtica dentata Hand

Indexed keywords

6,6',7,7' TETRAMETHOXYL 8,8' BISCOUMARIN; 7,7' DIHYDROXY 6,6' DIMETHOXY 8,8' BISCOUMARIN; 7,7' DIMETHOXY 6,6' BISCOUMARIN; COUMARIN DERIVATIVE; DAUCOSTEROL; PLANT EXTRACT; SCOPARONE; UNCLASSIFIED DRUG; URTICA DENTATA EXTRACT; VANILLIC ACID;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IC 50; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFRARED SPECTROSCOPY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MASS SPECTROMETRY; MEDICINAL PLANT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; REGULATORY T LYMPHOCYTE; STRUCTURE ANALYSIS; URTICA DENTATA;

ANIMALS; ANTIGENS, CD4; COUMARINS; DRUGS, CHINESE HERBAL; FORKHEAD TRANSCRIPTION FACTORS; HEP G2 CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SINCALIDE; SPLEEN; URTICACEAE;

URTICA;

EID: 77955593069     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2010.490779     Document Type: Article

References (20)

1. I. Rakin C. Ripoll Curr. Pharm. Des. 10, 3419 (2004)
2. J.R. Chen, Q. Lin, W.D. Melanie, and K.M. Alex, J. Flora. Chin. 5, 180 (2003).
3. D.R. Wan, J.C. Chen, and H. Yu, Hubei Yaocai Zhi (Hubei Science and Technology Press, Wuhan, 2002), p. 234.
4. M. Xiang, E. Tao, T. Chu, and S.Y. Yuan, Chin. J. Hosp. Pharm. 26, 1201 (2006).
5. M. Xiang, W.R. Hou, S.N. Xie, W.D. Zhang, and X. Wang, J. Ethnopharmacol. 126, 57 (2009).
6. Y.J. Yang, H.J. Lee, D.H. Choi, H.S. Huang, S.C. Lim, and M.K. Lee, Neurosci. Lett. 440, 14 (2008).
7. A. Estévez-Braun and A.G. González, Nat. Prod. Rep. 14, 465 (1997).
8. P.M. Dewick, Medicinal Natural Products. A Biosynthetic Approach (Wiley, England, 2002), p. 28.
9. J. Liu, Z. Feng, J.F. Xu, Y.H. Wang, and P.C. Zhang, Phytochemistry 68, 1775 (2007).
10. K. Mitsugi, B. Kimiye, M. Masafumi, N. Harumi, and H. Kiyoshi, Chem. Pharm. Bull. 22, 2746 (1974).
11. T.H. Joan and S.A. Brown,J. Chromatogr. 314, 323 (1984).
12. M.E. Morgan, R.P. Sutmuller, H.J. Witteveen, L.M. Van Duivenvoorde, E. Zanelli, C.J. Melief, A. Snijders, R. Offringa, R.R. De Vries, and R.E. Toes, Arthritis Rheum. 48, 1452 (2003).
13. H. Kopf, G.M. De la Rosa, O.M. Howard, and X. Chen, Int. Immunopharmacol. 7, 1819 (2007).
14. R.S. Mehugh and E.M. Shevach, Immunology 168, 5979 (2002).
15. G.J. Prud'homme and C.A. Piccirillo, J. Autoimmun. 14, 23 (2000).
16. S. Hori, T. Nomura, and S. Sakaguchi, Science 299, l057 (2003).
17. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky, Nat. Immunol. 4, 330 (2003).
18. J.D. Fontenot and A.Y. Rudensky, Nat. Immunol. 6, 331 (2005).
19. T. Kawaguchi, I. Matsumoto, and T. Osawa, J. Biol. Chem. 249, 2786 (1974).
20. D.B. Tully, B.J. Collins, J.D. Overstreet, C.S. Smith, G.E. Dinse, M.M. Mumtaz, and R.E. Chapin, Toxicol. Appl. Pharmacol. 168, 82 (2000).